Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapies

Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or chemotherapies

US Patent 9688761 · Granted Jun 27, 2017

Estimated economic value: $2,757,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Squeeze-type electrode connector2025
Delivery of biomolecules to PBMCs to modify an immune response2023
Nanoliposomal irinotecan for use in treating small cell lung cancer2022
Double-power-supply switching control system for a welding machine and method2021
Display screen or portion thereof with graphical user interface2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019